Endoplasmic reticulum stress signaling transmitted by ATF6 mediates apoptosis during muscle development by Nakanishi, Keiko et al.
T
H
E
J
O
U
R
N
A
L
O
F
C
E
L
L
B
I
O
L
O
G
Y
 
JCB: REPORT
 
©
 
 The Rockefeller University Press $8.00
The Journal of Cell Biology, Vol. 169, No. 4, May 23, 2005 555–560
http://www.jcb.org/cgi/doi/10.1083/jcb.200412024
 
JCB 555
 
Endoplasmic reticulum stress signaling transmitted 
by ATF6 mediates apoptosis during muscle 
development
 
Keiko Nakanishi,
 
1,2,4
 
 Tatsuhiko Sudo,
 
1,3
 
 and Nobuhiro Morishima
 
1,2
 
1
 
Bioarchitect Research Group, 
 
2
 
Cellular and Molecular Biology Laboratory, and 
 
3
 
Antibiotics Laboratory, Institute of Physical and Chemical Research, Wako, 
Saitama 351-0198, Japan
 
4
 
Department of Biological and Environmental Science, Faculty of Science and Engineering, Saitama University, Saitama, Saitama 338-8570, Japan
 
lthough apoptosis occurs during myogenesis, its
mechanism of initiation remains unknown. In a
culture model, we demonstrate activation of
caspase-12, the initiator of the endoplasmic reticulum
(ER) stress-speciﬁc caspase cascade, during apoptosis
associated with myoblast differentiation. Induction of ER
stress-responsive proteins (BiP and CHOP) was also
observed in both apoptotic and differentiating cells.
ATF6, but not other ER stress sensors, was speciﬁcally
A
 
activated during apoptosis in myoblasts, suggesting that
partial but selective activation of ER stress signaling was
sufﬁcient for induction of apoptosis. Activation of caspase-
12 was also detected in developing muscle of mouse
embryos and gradually disappeared later. CHOP was
also transiently induced. These results suggest that speciﬁc
ER stress signaling transmitted by ATF6 leads to naturally
occurring apoptosis during muscle development.
 
Introduction
 
The central executioner molecules of apoptosis are a family of
cysteine proteases, the caspases, which comprise multiple
cascades (Degterev et al., 2003). All caspases are synthesized
as precursor proteins, procaspases, which are activated by
processing to 
 
 
 
20- (p20) and 10-kD (p10) mature fragments.
Apoptosis is often associated with differentiation during devel-
opment (Glücksmann, 1951). However, the cause of apoptosis
and the mechanism of initiation of caspase activation during
differentiation remain largely unknown. The present study
focuses on the triggering of caspase activation during myoblast
differentiation. Myoblast cells begin to exhibit considerable
morphological changes when cultures are altered to low
concentrations of mitogens. During this process, myoblasts
express muscle-specific proteins and fuse into multinucleated
myotubes (Stockdale and Holtzer, 1961; Nadal-Ginard 1978).
Myoblast fusion is associated with apoptosis (Fidzianska and
Goebel, 1991), and activation of caspase-3, usually a down-
stream caspase, was detected in a cell culture model (Dee et al.,
2002; Fernando et al., 2002). The caspase initiator responsible
for caspase-3 activation is unknown.
Because caspase-12 is highly expressed in muscle of
adult (Van de Craen et al., 1997) and embryonic mice (described
later), it might play a physiological role in muscle tissue. It
is an ER stress-specific caspase, functioning as the initiator
caspase in response to ER stress, that involves accumulation of
misfolded proteins in the ER (Nakagawa et al., 2000). Due to
the nature of apoptotic stimuli, the effects of caspase-12 have
been often discussed regarding pathological changes, especially
in relation to neurodegenerative disorders (Nakagawa et al.,
2000) and prion diseases (Hetz et al., 2003). We previously
found that caspase-12 initiates the ER stress-specific cascade
involving caspases-12, -9, and -3 in a myoblast cell line,
C2C12 (Morishima et al., 2002), indicating that caspase-12 can
function as an initiator caspase in myoblasts for implementation
of apoptosis.
ER stress-induced apoptosis is preceded by activation of
a cytoprotective signaling cascade termed the unfolded protein
response (UPR). The UPR alters transcriptional and trans-
lational programs to cope with accumulation of unfolded or
misfolded proteins. Although protein synthesis is generally
down-regulated in the UPR, decreasing the load in the ER,
the UPR induces a group of specific proteins, including BiP, an
ER-specific molecular chaperone, and CHOP, a transcription
factor known to be up-regulated by ER stress (Zhang and
Kaufman, 2004). We demonstrate that both BiP and CHOP are
induced in both apoptotic cells and differentiating myoblasts,
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indicating that differentiation conditions elicit ER stress-spe-
cific signaling. Under such conditions, activation of caspase-12
was detected, suggesting a previously unidentified role of ER
stress signaling in activating the ER-specific caspase cascade
to induce naturally occurring apoptosis during development.
 
Results and discussion
 
Proliferating myoblasts undergo terminal differentiation in
vitro under standard differentiation conditions (Stockdale and
Holtzer, 1961; Nadal-Ginard, 1978) when cultures are changed
to low concentrations of mitogens (differentiation medium
[DM]). Approximately 15% of C2C12 cells died during the
first 24 h of incubation in DM (Fig. 1 A); thereafter, the per-
centage of dead cells gradually decreased over a week, in paral-
lel with myotube formation. Seven days after switch to DM,
myotubes were abundant and apoptosis had almost ceased (Fig.
1 A). On day 3, formation of myosin was evident in multinu-
cleated myotubes (Fig. 1 B). We collected apoptotic cells that
were either floating or loosely attached to the plates by centrif-
ugation and recovered living cells by scraping the plates. At
day 1, Western blot analysis showed that procaspase-12 (48
kD) had been extensively processed to its active forms in apop-
totic cells and remained largely unchanged in living cells (Fig.
1 C). The sizes of the active forms (35 and 28 kD) in these ap-
optotic cells were the same as observed during apoptosis in re-
sponse to thapsigargin, an inhibitor of ER-specific calcium
ATPase (Morishima et al., 2002). To our knowledge, this is the
first example of activation of caspase-12 under nonpathologi-
cal conditions.
In the ER stress-specific cascade, caspase-12 activates
caspase-9, which then catalyzes cleavage of procaspase-3
(Morishima et al., 2002). Consistent with this finding, we de-
tected considerable activation of caspase-9 and -3 as well as
cleavage of vimentin by caspase-9 (Nakanishi et al., 2001) in
apoptotic C2C12 cells cultured in DM (Fig. 1 D). However,
mitochondrial transmembrane potential was maintained in
more than 80% of apoptotic cells (Fig. 1 D), suggesting that the
mitochondrial pathway is not important in apoptosis during
myoblast differentiation, as in the case of apoptosis of C2C12
cells induced by ER stressors (Morishima et al., 2002).
We examined stable transfectants of C2C12 overexpress-
ing a caspase-12–specific suppressor, MAGE-3, which are re-
sistant to ER stress inducers but not to other apoptotic stimuli
(Morishima et al., 2002). The transfectant cells underwent myo-
tube formation with a much lower rate of apoptosis (
 
 
 
1%)
than did the parental C2C12 cells (Fig. 1 E). Activation of
caspases (-12, -9, and -3) was not detected in the transfectants
(unpublished data). These results suggest that execution of
apoptosis during myotube formation is mainly dependent on
the ER-specific cascade. Myoblast differentiation may proceed,
to some extent, without caspase activation because the trans-
fectants expressed myosin, which is in parallel with morpho-
logical changes (Fig. 1 E).
Western blot analysis showed that BiP was induced at
comparable levels in dying and living cells (Fig. 2 A), indicat-
ing that the UPR is activated under differentiating conditions,
irrespective of cell fate. At day 5, myosin was expressed in ap-
optotic cells in DM, indicating that apoptosis takes place even
after partial cell differentiation (Fig. 2 B).
The evidence for ER stress signals provided by the induc-
tion of BiP is supported by the immunocytochemistry of the
C2C12 cells. One day after the cells were transferred to DM,
CHOP was induced and accumulated in the nuclei of over 80% of
differentiating myoblasts (Fig. 2 C). CHOP induction was also
detected in MAGE-3 transfectants (Fig. 2 D), suggesting that gen-
eration of ER stress is an upstream event of caspase activation.
Nuclear accumulation of CHOP was still evident at day 2
(
 
 
 
40%), when the differentiating cells began to fuse into myo-
tubes (Fig. 2 C). However, only a fraction of them underwent
Figure 1. The ER stress-specific caspase
cascade is activated during myoblast differ-
entiation. (A) Induction of either apoptosis or
myotube formation. Phase-contrast images of
cells are shown. Note that the small round
cells in growing culture (GM) are mitotic cells.
Bars, 200  m. (B) Expression of myosin in
multinucleated myotubes detected by immuno-
cytochemistry with antimyosin antibody. Bars,
100  m. (C) Activation of caspase-12 in apop-
totic cells examined by Western blot analysis.
Arrowheads depict active forms of caspase-12
detected with anti–caspase-12 mAb. D, dead
cells; L, live cells. As controls, cells treated with
1   M thapsigargin (24 h) were also exam-
ined. (D) Western blot analysis of caspase-9
and -3 (left). Arrowheads depict active forms.
Vimentin cleavage was detected by anti-V1
antibody (Nakanishi et al., 2001). Integrity of
mitochondrial transmembrane potential was
examined using the JC-1 reagent, which stains
intact mitochondria orange (right). Apoptotic
cells are indicated by arrowheads. Bars, 20
 m. (E) Suppression of apoptosis in MAGE-3-
transfected cells cultured in DM at day 1. Left,
phase-contrast; right, antimyosin immunostain-
ing. Bars, 200  m. 
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apoptosis on day 2 or thereafter. Thus, nuclear localization of
CHOP did not necessarily induce apoptosis. CHOP immuno-
staining was detected in the cytoplasm at a later stage of differ-
entiation (Fig. 2 C), suggesting that CHOP translocates into the
nucleus at an early stage and later moves back out, being no
longer functional as a transcription factor. Stress is probably re-
duced during differentiation, allowing most cells to recover and
differentiate into myotubes.
To gain insight into the mechanism of induction of cas-
pase-12 activation in C2C12 cells in DM, we examined activa-
tion states of upstream factors that sense ER stress. Three ER-
resident transmembrane proteins have been identified as proximal
sensors of ER stress: the kinase and endoribonuclease IRE1,
PERK kinase, and the transcription factor ATF6 (Rutkowski
and Kaufman, 2004). In the cases of IRE1 and PERK, ER stress
induces autophosphorylation and activation. In contrast, ER
stress leads to ATF6 transit to the Golgi complex, where it is
cleaved for activation by the protease S1P, and then by S2P.
These sensors comprise parallel pathways that are connected by
signal cross talk through gene expression. Activation of these
pathways can be assessed by posttranslational modification of
these sensors themselves or by their downstream targets; e.g.,
generation of a splicing variant of XBP1 by active IRE1.
Culturing C2C12 cells under differentiation conditions re-
sulted in activation of the ATF6 pathway in dying cells but not of
IRE1 and PERK (Fig. 3 A). Although PERK seemed to be con-
stitutively active in live cells in growth medium, active PERK
disappeared in DM. In control experiments, the ER stressors tu-
nicamycin (inhibitor of 
 
N
 
-glycosylation) and thapsigargin also
activated ATF6 specifically in dying cells and IRE1/XBP in both
living and dying cells (Fig. 3 A). Active PERK was detected in
surviving cells, whereas it again disappeared in dying cells
treated with ER stressors. The reason for disappearance of active
PERK from these dying cells is unknown. These results suggest
that active ATF6 plays a decisive role in induction of apoptosis
in C2C12 cells, whereas activation of IRE1 or the PERK path-
way is not required for apoptosis. ER stress during myoblast dif-
ferentiation may be weaker than that generated by ER stressors,
so that it activates only the ATF6 pathway.
Next, we treated C2C12 cells with a serine protease inhibi-
tor, 4-(2-aminoethyl)benzenesulfonylfluoride (AEBSF), which
specifically inhibits S1P (Okada et al., 2003). At days 1 and 2,
Figure 2. ER stress signals are generated in C2C12 cells in DM. (A) Induction
of BiP in dying (D) and living (L) cells determined by Western blot analysis.
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) acted as loading
control. Cells treated with 1  M thapsigargin (24 h) were also examined
as positive controls. (B) Myosin was expressed in both apoptotic cells and
differentiating cells. (C) Detection of induction of CHOP by immuno-
cytochemical analysis of differentiating C2C12 cells. Bars, 100  m. (D)
CHOP induction in MAGE-3 transfectants. Bars, 100  m.
Figure 3. ATF6 is important in caspase-12 activation during myotube
formation. (A) Activation states of ER stress sensors. Western blot analysis
of myoblast cells cultured in DM for 24 h. L, live cells; D, dying cells.
As positive controls, cells treated with either 2  g/ml tunicamycin or 1  M
thapsigargin for 24 h were included in the analysis. (B) AEBSF inhibits
apoptosis in C2C12 cells in DM. Proliferating cells were pretreated with
400  M AEBSF or 100  M p-APMSF for 1 h, and then transferred to DM
in the presence of inhibitor for 24 or 48 h. Bars, 200  m. (C) AEBSF
treatment prevents induction of CHOP and myosin. Cells were immuno-
stained by anti-CHOP antibody and antimyosin antibody. Bars: (CHOP)
50  m; (Myosin) 100  m. 
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AEBSF in DM conferred resistance to differentiation-associated
apoptosis, resulting in little cell death (Fig. 3 B), with neither ac-
tivation of ATF6 and caspase-12 (not depicted) nor induction of
CHOP and myosin (Fig. 3 C). Control experiments using another
serine protease inhibitor, 4-amidinophenylmethanesulfonyl fluo-
ride (p-APMSF), revealed neither a protective effect against
apoptosis (Fig. 3 B) nor prevention of induction of CHOP and
myosin (Fig. 3 C). Although this result suggests the importance
of the ATF6 pathway in apoptosis, transient transfection of the
cleaved form of ATF6 did not enhance apoptosis in DM (unpub-
lished data). It seems likely that an additional signal pathway is
also involved in apoptosis induction.
We could not detect activation of ATF6 in live cells (Fig.
3 A), in which both BiP and CHOP were induced. BiP and
CHOP are induced by either active ATF6 or IRE1, the former
being upstream of the latter (Rutkowski and Kaufman, 2004).
It is possible that activation of these sensors is below the level
of detection in Western blot analysis.
To confirm involvement of caspase-12 in myogenesis in
vivo, we examined caspase-12 activation in developing muscle
tissues. We generated specific antibodies (Nakanishi et al.,
2001) to active caspase-12, which recognized the COOH termi-
nus of the p20 subunit as well as to the NH
 
2
 
 terminus of the p10
subunit (Fig. S1, available at http://www.jcb.org/cgi/content/
full/jcb.200412024/DC1).
Immunostaining of embryonic muscle tissues with anti–
caspase-12 monoclonal antibody was negative in embryonic day
(E) 12.5 sections (not depicted); however, at E13.5, E15.5, and
E18.5, caspase-12 was abundant in filamentous cells of muscle
tissues around the neck, tongue, and back (Fig. 4 A). At E13.5,
about half of the filamentous muscle cells in this region reacted
with the antibody to active caspase-12, and intensity of staining
decreased at E15.5 and E18.5 (Fig. 4 B), suggesting the presence
of transient ER stress. Staining with caspase-12 monoclonal anti-
body was detected throughout filamentous cells, with more in-
tense signals around the nucleus (Fig. 4 C), whereas the signals
obtained with the two anti-active caspase-12 antibodies were
generally restricted to the region around the nucleus (Fig. 4 C).
Evidently, only a fraction of caspase-12 molecules are activated
in these tissues. Double-staining of these cells with active cas-
pase-12 antibody and antimyosin antibody showed that activated
caspase-12 was indeed present in cells undergoing differentia-
tion, and thus does not necessarily induce apoptosis (Fig. 4 C).
Only tissue sections at E13.5 appeared to express CHOP,
indicating that CHOP induction is transient (Fig. 4 D). This
finding coincides with the onset of caspase-12 expression (Fig.
4 A), as well as muscle-tissue formation (Ontell and Kozeka,
1984), in the developing mouse. CHOP exhibited either nu-
clear or cytoplasmic location (Fig. 4 E). This pattern is similar
to that observed in the culture model (Fig. 2 C), perhaps re-
flecting the production and subsequent extinction of stress sig-
nals. It is possible that CHOP leaves the nucleus as the result
of decrease in ER stress. Double-staining of muscle tissues
showed that caspase-12 is activated in cells that express CHOP
(Fig. 4 F). These findings suggest that activation of caspase-12
by ER stress occurs in these myoblasts.
Figure 4. Activation of caspase-12 and induction of CHOP in developing
muscle tissue. (A) Caspase-12 was induced at the onset of muscle formation
at E13.5 in embryo back muscle tissue. (B) Back muscle at E13.5 was
specifically stained with antibody to active caspase-12. (C) Higher magni-
fication of images in A and B. The muscle tissue at E13.5 was stained with
antibody to caspase-12. Also shown is double-labeling of cells with anti-
active caspase-12 antibody (brown) and antimyosin antibody (purple).
(D and E) CHOP induction in back muscle tissues at E13.5. Arrows indicate
nuclear accumulation of CHOP, whereas arrowheads point to cells with
cytoplasmic CHOP. (F) Activation of caspase-12 in the presence of CHOP
induction. Anti-p10N antibody, purple; CHOP, brown. Bars: (A, B, and D)
100  m; (C, E, and F) 10  m.
Figure 5. Activation of the ER stress-specific caspase cascade in apoptotic
cells in developing muscle tissue at E13.5. (A) Small round cells stained by
anti-active caspase-12 antibodies contained condensed nuclei (arrow-
heads). Nuclei were stained by Gill’s modified hematoxylin solution
(Merck). (B) Small round cells stained with anti-V1 and anti-active caspase-3
antibodies. Bars, 10  m. 
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A few of the immunopositive cells were apoptotic (round
cells with condensed nuclei; Fig. 5 A). However, other positive
cells were filamentous (Fig. 4 C), indicating that most of the
stained cells were not apoptotic but differentiating. Activation of
caspase-9 and -3 was also detected in the round cells (Fig. 5 B).
A single section might contain a few cells undergoing apoptosis
because of caspase-9 and -3 activation. It seems likely that acti-
vation of caspase-12 does not always result in full activation of
downstream caspases and that antiapoptotic proteins such as
XIAPs might inhibit downstream caspases (Deveraux and Reed,
1999). Most of the cells probably experience stress when they
start to differentiate, but only a small minority die, whereas the
majority differentiate toward the terminal phenotype.
In summary, we propose that ER stress signaling, espe-
cially that mediated by ATF6, plays a role in the induction of de-
velopmental apoptosis in muscle tissues through activation of
caspase-12. Identification of ER stress as a trigger was made pos-
sible by detection of caspase-12 activation because its activation
is nearly synonymous with generation of ER stress. Because the
major cause of apoptosis appears to be ER stress, we speculate
that this type of apoptosis contributes to selecting out of a sub-
population of cells that are vulnerable to cellular stress. Our find-
ings also imply that differentiating myoblasts suffer cellular
stress, and thus provide clues to how myotube formation is regu-
lated in vivo. ER stress and its downstream signaling might play
roles in myogenesis, in addition to apoptosis. One remaining is-
sue is how ATF6 signaling is activated at the beginning of differ-
entiation. Changes in the ER, other than accumulation of mis-
folded proteins, may cause specific activation of ATF6. The
suggestion that caspase activation is involved in myoblast differ-
entiation by itself (Fernando et al., 2002) must also be consid-
ered. Caspase-12 knockout mice develop normally (Nakagawa et
al., 2000), indicating that caspase-12–dependent apoptosis is not
essential for muscle development. Although caspase-12 plays a
major role in ER stress-induced apoptosis, caspase-12
 
 
 
/
 
 
 
 cells
are still sensitive to ER stress (Nakagawa et al., 2000), suggesting
that a mechanism other than that involving caspase-12 also par-
ticipates in execution of apoptosis in response to ER stress. Re-
cent studies have shown that ER stress can induce caspase-9 by a
mitochondria-dependent and probably caspase-12–independent
route in several cell lines (Häcki et al., 2000; Ito et al., 2001). It is
thus possible that other caspases, such as caspase-9, compensate
for the absence of caspase-12, as such compensatory effects are
sometimes observed in caspase knockout mice (Zheng et al.,
2000). Nevertheless, our study strongly suggests that ER stress
plays an important role in triggering apoptosis associated with
muscle development because activation of caspase-12 was de-
tected in all the apoptotic cells in differentiating muscle tissues.
 
Materials and methods
 
Creation of antibodies to caspase-12 fragments
 
Cleavage-site–directed antibodies were prepared as described previously
(Nakanishi et al., 2001). Immunizing rabbits with the synthetic peptides
CRYNGTINVSTNKGIATAD and TDEERC generated an anti-p20 antibody
and an anti-p10N antibody, respectively.
 
Cell culture
 
C2C12 cells were grown in medium with 10% FCS as described previ-
ously (Morishima et al., 2002). Differentiation was induced in medium
with 2% horse serum (Invitrogen) and 1 
 
 
 
g/ml insulin (Sigma-Aldrich). Mi-
tochondrial transmembrane potential was examined by staining cells with
JC-1 reagent (Molecular Probes), according to the manufacturer’s proto-
col. For inhibition studies, either 400 
 
 
 
M AEBSF or 100 
 
 
 
M p-APMSF
(Sigma-Aldrich) was included in the medium. Effective concentrations of
these inhibitors are 100–1,000 
 
 
 
M (AEBSF) and 10–100 
 
 
 
M (p-APMSF),
as suggested by the manufacturer. Transfection was performed as de-
scribed previously (Morishima et al., 2002). The active ATF6 cDNA was
provided by K. Mori (Kyoto University, Kyoto, Japan).
 
Immunocytochemistry
 
C2C12 cells grown in 8-chamber slides (Nunc) were fixed in 4% PFA/PBS
for 10 min and permeabilized in 0.1% Triton X-100 for 20 min. In some
cases, they were fixed and permeabilized in methanol at 
 
 
 
20
 
 
 
C for 2
min. The fixed and permeabilized cells were blocked in PBS containing
3% BSA (Jackson ImmunoResearch Laboratories) and incubated overnight
at 4
 
 
 
C with primary antibodies in blocking solution. Immunoreactivity was
detected with either Alexa-conjugated secondary antibody (Molecular
Probes) or a combination of biotin-conjugated secondary antibody (Vector
Laboratories) and Alexa-conjugated streptavidin (Molecular Probes).
 
Western blot analysis
 
Cells were lysed in SDS-PAGE sample buffer and homogenized. Western
blot analysis was performed as described previously (Morishima et al.,
2002).
 
Immunohistochemistry
 
Paraffin-embedded sections were prepared as described previously (Naka-
nishi et al., 2001). For immunohistochemistry, sections were rehydrated
through a graded series of alcohols, rinsed in PBS, and blocked in PBS con-
taining 2% normal serum. After overnight incubation with primary antibody
at 4
 
 
 
C, immunoreactivity was detected using a TSA Fluorescein System
(NEN Life Science Products) followed by incubation with 3,3
 
 
 
-DAB (Wako
Chemicals). For double-staining, DAB and VIP substrate (Vector Laborato-
ries) were used for discrimination of different primary antibodies. TUNEL
staining was performed as described previously (Nakanishi et al., 2001).
 
Microscopy
 
Immunostained images were captured with an ORCA-ER cooled charge-
coupled camera (Hamamatsu Photonics) mounted on a microscope (model
BX51; Olympus). All images were captured at either 10-, 20-, or 40-fold
magnification using Plan-Apochromat objective lenses (10
 
 
 
, 0.40 NA;
20
 
 
 
, 0.70 NA; 40
 
 
 
, 0.85 NA). Images were acquired and processed
using IPLab software (Scanalytics). Selected images were pseudocolored
for presentation using Adobe Photoshop. Live cells during culture were ob-
served under a microscope (model IX-70; Olympus) using a 4
 
 
 
 Plan-Semi-
Apochromat lens (0.13 NA).
 
Antibodies
 
Primary antibodies used for immunostaining were anti–caspase-12 p20
(this study), anti–caspase-12 p10N (this study), anti–caspase-12 (Naka-
gawa et al., 2000; provided by J. Yuan, Harvard Medical School,
Boston, MA), anti–caspase-9 (Medical and Biological Laboratories), anti–
vimentin V1 (Nakanishi et al., 2001), anti-active caspase-3 and anti-
phospho PERK (Cell Signaling Technology), anti-CHOP, anti-ATF6, and
anti-XBP1 (Santa Cruz Biotechnology, Inc.), anti-BiP (Transduction Labora-
tories), antimyosin (Progen; Sigma-Aldrich), anti-GAPDH (Chemicon), and
anti-hexahistidine (CLONTECH Laboratories, Inc.).
 
Online supplemental material
 
Fig. S1 shows the efficacy of anti-active caspase-12, which was confirmed
by specifically stained, paraffin-embedded sections of adult mouse kidney
treated with tunicamycin. Also shown are TUNEL-positive staining, induc-
tion of CHOP, cleavage of vimentin by caspase-9, and active caspase-3
in the damaged kidney. Online supplemental material is available at http:
//www.jcb.org/cgi/content/full/jcb.200412024/DC1.
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